Mucormycosis, Pathophysiology


Last updated: 2021 Sep 28
Total hit(s): 6
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
Out of the 127 COVID-19 associated mucomycosis patients at an ophthalmic centre, 13 patients with no history of diabetes developed uncontrolled diabetes followed by rhino-orbital mucormycosis. Use of steroids for treatment of COVID-19 was the major cause of new onset of diabetes. COVID-19 treatment in younger patients should be carefully monitered.
34338124
(Orbit)
PMID
34338124
Date of Publishing: 2021 Aug 1
Title Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients
Author(s) nameNair AG, Adulkar NG et al.
Journal Orbit
Citation count 1
Date of Entry 2021 Sep 28


Poor control of diabetes in COVID-19 patients is an important risk factor for COVID assoaciated mucormycosis. Covid-19 infected patients with a history of diabetes and hypertension treated with corticosteroids developed Rhino-orbital mucormycosis. No death as a result of known COVID-19 issues were reported.
34096653
(Mycoses)
PMID
34096653
Date of Publishing: 2021 Jun 7
Title Mucormycosis in patients with Covid-19:A cross-sectional descriptive multicentre study from Iran.
Author(s) namePakdel F, Ahmadikia K et al.
Journal Mycoses
Impact factor
3.05
Citation count: 1
Date of Entry 2021 Sep 28


In a patient with diabetes and hypertension undergoing COVID-19 treatment, a combination of pulmonary aspergillosis and mucormycosis was reported. In critically ill patients, pulmonary aspergillosis and mucormycosis can be a seondary complication of COVID-19 in severely ill patients.
33842203
(Med Mycol Case Rep)
PMID
33842203
Date of Publishing: 2021 Jun
Title Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Author(s) nameJohnson AK, Ghazarian Z et al.
Journal Med Mycol Case Rep
Impact factor
0.702
Citation count: 1
Date of Entry 2021 Sep 28


A COVID-19 patient with hypertension had acute respiratory failure and was treated with broad spectrum antibiotics and corticosteroids. The patient developed pulmonary mucormycosis. The patient had multiple organ dysfunction syndrome with sequential organ failure assessment (SOFA) of 14.
33331988
(Infection)
PMID
33331988
Date of Publishing: 2020 Dec 17
Title A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
Author(s) namePasero D, Sanna S et al.
Journal Infection
Impact factor
2.84
Citation count: 1
Date of Entry 2021 Sep 28


A COVID-19 patient with hypertension had acute respiratory failure and was treated with broad spectrum antibiotics and corticosteroids. The patient developed primary gastric mucormycosis five days after ICU admission.
33207116
(Clin Endosc)
PMID
33207116
Date of Publishing: 2020 Nov
Title Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report
Author(s) nameMonte Junior ESD, Santos MELD et al.
Journal Clin Endosc
Impact factor
1.84
Citation count: 2
Date of Entry 2021 Sep 28


A COVID-19 patient with a history of diabetes was treated with broad spectrum antibiotics and steroids. Over the course of treatment, he developed signs of orbital cellulitis and soft tissue swelling in the retrobulbar regions. Nasal biopsy showed aseptate filamentous fungal hyphae suggestive of mucomycosis
33145132
(Cureus)
PMID
33145132
Date of Publishing: 2020 Sep 30
Title Rhino-Orbital Mucormycosis Associated With COVID-19
Author(s) name Mehta S, Pandey A.
Journal Cureus
Impact factor
Cant find
Citation count: 2
Date of Entry 2021 Sep 28